Skip to main content

908 Devices Inc. (MASS) Stock Forecast

Data as of Sep 19, 2026

Healthcare · Current price $10.62 (-3.28%)

Consensus Target
$12.00
Upside
+13.0%
Analysts
2
Rating
Buy(2.00)

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Buy
Strong Buy0
Buy2
Hold0
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

MASS vs Sector & Market

MetricMASSHealthcare AvgLarge Cap Avg
Analyst Rating2.002.262.42
Analyst Count2818
Target Upside+13.0%+22243.7%+21.5%
P/E Ratio12.523.7538.34

Revenue Estimates

PeriodLowAvgHigh#
2026-09-30$16M$17M$18M2
2026-12-31$19M$20M$21M3
2027-03-31$16M$16M$17M3
2027-06-30$17M$18M$19M2
2027-09-30$19M$20M$21M2
2027-12-31$22M$23M$24M3
2028-12-31$86M$87M$88M2
2029-12-31$100M$102M$103M3

EPS Estimates

PeriodLowAvgHigh#
2026-09-30$-0.10$-0.09$-0.081
2026-12-31$-0.04$-0.04$-0.031
2027-03-31$-0.09$-0.08$-0.071
2027-06-30$-0.09$-0.08$-0.071
2027-09-30$-0.05$-0.04$-0.041
2027-12-31$-0.01$-0.01$-0.011
2028-12-31$-0.37$-0.36$-0.351
2029-12-31$-0.20$-0.20$-0.201

Frequently Asked Questions

What is the analyst consensus for MASS?

The consensus among 2 analysts covering 908 Devices Inc. (MASS) is Buy with an average price target of $12.00.

How many analysts cover MASS?

2 analysts have issued ratings for 908 Devices Inc. in the past 12 months.

Is MASS a buy or sell right now?

Based on 2 analyst ratings, MASS has a consensus rating of Buy (2.00/5) with a +13.0% upside to the consensus target of $12.00.

What are the earnings estimates for MASS?

Analysts estimate MASS will report EPS of $-0.09 for the period ending 2026-09-30, with revenue estimated at $17M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.